Juárez-Caballero G, Cabrera-Muñoz ML, Gallegos-Castorena S, Muñiz-Ronquillo T

Language: Spanish
References: 31
Page: 49-58
PDF size: 278.13 Kb.

ABSTRACT

No abstract

REFERENCES

1. Golub RT. Acute myelogenous leukemia. En: Pizzo A, Philip MD, Poplack G, David MD, editores. Principles and practice of pediatric oncology. 5th ed. Philadelphia: Lippincott Williams and Wilkins; 2006. p. 5590-608.

2. Porcu P, Cripe LD, Ng EW, Bhatia S, Danielson CM, Orazi A, et al. Hyperleukocytic leukemias and leukostasis: a review of pathophysiology, clinical presentation and management. Leuk Lymphoma. 2000; 39: 1-18.

3. Hastings C. Oncologic emergencies. En: Hastings C, editor. The Children’s Hospital Oakland Hematology/Oncology handbook. St Louis: Mosby Handbook; 2002. p. 153-9.

4. Litchman MA. Rheology of leukocytes, leucocyte suspensions, and blood in leucemia. J Clin Invest. 1973; 52: 350-8.

5. Marshall AL, Rowe MJ. Hyperleukocyte leukemia: rheological, clinical and therapeutic consideration. Blood. 1982; 60: 279-83.

6. Ringengerg QS, Doll DC. Acute nonlymphocytic leukemia. The first 48 hours. South Med J. 1990; 83: 931-40.

7. Taylor SD. Oncologic Emergencies. http://www.emedicine.com/ped/topic2590.htm. Last updated December 2006.

8. Bunin NJ, Pui CH. Differing complications of hyperleukocytosis in children with acute lymphoblastic or acute nonlymphoblastic leukemia. J Clin Oncol. 1985; 3: 1590-5.

9. Ching-Hon P. Pathology of acute myeloid leucemia. En: Lilleyman J, Hann I, Blanchette V, editores. Pediatric hematology. 2nd ed. London: Churchill Livingston; 1999. p. 329-80.

10. Nelson SC, Bruggers CS. Management of leukemic hyperleukocytosis with hidratation, urinary alkalinization and allopurinol. Are cranial irradiation and invasive cytoreduction necessary? Am J Pediatr Hematol Oncol. 1993; 15: 351-5.

11. Lascari AD. Improvement of leukemic hyperleukocytosis with only fluid and allopurinol therapy. Am J Dis Child. 1991; 145: 969-70.

12. Harris AL. Leukostasis associated with blood transfusion in acute myeloid leukemia. BMJ. 1978; 6121: 1169-71.

13. Bunin NJ, Kunket K, Callihan TR. Cytoreduction procedures in early management in cases of leukemia and hyperleukotosis in children. Med Pediatr Oncol. 1987; 15: 232-5.

14. Goenka P, Chait M, Hitti IF. Acute leukostasis pulmonary distress syndrome. J Fam Pract. 1992; 35: 445-9.

15. Navkeet S, Majhaik L. Acute leukemia with a very high leukocyte count: Confronting a medical emergency. Clev Clin J Med. 2004; 71: 633-7.

16. Porcu P, Danlelson CF, Heeremia NA. Therapeutic leukapheresis in hyperleukocytic leukemias: lack of correlation between the degree of cytoreduction and early mortality rate. Br J Haematol. 1997; 98: 433-6.

17. Giles FJ, Shen Y, Kantarijan HM. Leukapheresis reduces early mortality in patients with acute myeloid leukemia with a high white cell counts but does not improve long term survival. Leuk Lymphoma. 2001; 42: 63-73.

18. Colman R, Rubin RH. Disseminated intravascular coagulation due to malignancy. Semin Oncol. 1990; 17: 172-86.

19. Dabrow MB, Wilkins JC. Management of hyperleukocytic syndrome, DIC and thrombotic thrombocytopenia purpura. Postgrad Med. 1993; 93: 192-202.

20. Nand S, Messmore H. Hemostasis in malignancy. Am J Hematol. 1990; 35: 45-55.

21. Filippatos TD, Milionis HJ, Elisaf MS. Alterations in electrolyte equilibrium in patients with acute leukemia. Eur J Haematol. 2005; 75: 449-60.

22. Creutzig U, Ritter J, Budde M. Early deaths due to hemorrhage and leukostasis in childhood acute myelogenous leukemia. Association with hyperleukocytosis and acute monocytic leukemia. Cancer. 1987; 60: 3071-9.

23. Creutzig U, Zimmermann M, Reinhardt D, Dworzak M, Stary J. Early deaths and treatment-related mortality in children undergoing therapy for acute myeloid leukemia: analysis of the multicenter clinical trials AML-BFM 93 and AML-BFM 98. J Clin Oncol. 2004; 21: 4384-93.

24. Pérez-Navero JL, Marroquin-Yañez L, Ibarra-de la Rosa I, Gómez-García P. Presentación inusual de leucemia mieloblástica aguda en dos pacientes pediátricos. An Esp Pediatr. 2002; 56: 571-5.

25. Sallah S, Wan JY, Nguyen NP, Hanrahan LR, Sigouna G. Disseminated intravascular coagulation in solid tumors. Thromb Hemost. 2001; 86: 828-33.

26. Gibson BES, Wheatley K, Hann IM, Stevens RF, Webb D, Hills RK, et al. Treatment strategy and long term results in paediatric patients treated in consecutive UK AML trials. Leukemia. 2005; 19: 2130-8.

27. Kardos G, Zwaan CM, Kaspers GJL, de Graaf SSN, de Bont ESJM, Postma A, et al. Treatment strategy and results in children treated on three Dutch Childhood Oncology Group acute myeloid leukemia trials. Leukemia. 2005; 19: 2063-71.

28. Kaspers GJL, Creutzig U. Pediatric acute myeloid leukemia: international progress and future directions. Leukemia. 2005; 19: 2025-9.

29. Pession A, Rondelli R, Basso G, Rizzari C, Testi AM, Fagioli F, et al. Treatment and long-term results in children with acute myeloid leukaemia treated according to the AIEOP AML protocolos. Leukemia. 2005; 19: 2043-53.

30. Armendariz H, Fernández-Barbieri MA, Freigeiro D, Lastiri F, Felice MS, Dibar E, et al. Treatment strategy and long-term results in pediatric patients treated in two consecutive AML-GATLA trials. Leukemia. 2005; 19: 2139-42.

31. Creutzig U, Zimmerman M, Ritter J, Reinhardt D, Hermann J, Henze G, et al. Treatment strategies and long-term results in paediatric patients treated in four consecutive AML-BFM trials. Leukemia. 2005; 19: 2030-42.